AbbVie

Open: 133.71 Close: 136.87 Change: 3.16

How to know if AbbVie Company Inc is a risky investment without reading the whole internet.

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab. AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction.

Today's News

AbbVie Inc. (ABBV) latest press releases | seeking alpha. abbvies rinvoq passes midstage test in systemic lupus erythematosus. AbbVie Inc (ABBV) stock price today, news, quotes, faqs and fundamentals. The current Abbvie [ ABBV ] share price is $136.87. AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab. AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences. Analysts estimate an earnings decrease this quarter of$0.46 per share, a decrease next quarter of $0.01. Zacks Rank #3 (Hold) for AbbVie is graded B on this front, indicating that it is trading at a discount. AbbVie stock (NYSE: ABBV) is a better pick than its industry peer, Merck stock. Merck trades at a slightly higher valuation of 4.8x trailing revenues, compared to 4.2x for Abbvie. 2023 will be a painful year with a decline in sales. AbbVie Inc (ABBV) stock is lower by -3.75% while the S&P 500 is down -0.13% as of 9:48 AM on Thursday, Jun 1. ABBV stock has gained 51% since 2019 primarily due to favorable change in revenues. AbbVie will be presenting new data across our #oncology portfolio and pipeline, including some of the most difficult to treat forms of blood cancer to #NSCLC and other solid tumors. AbbVie stock price has not been tested for use with Barchartart.com. Abbvie and Amgen Motley Motley are moving forward.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, ABBV, Inc, price, Abbvie, test, and the most common words in the summary are: abbvie, stock, market, job, abbv, news, company, . One of the sentences in the summary was: AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #job #abbv #news #company.